ask="11.250"
ask_size="900"
average_daily_volume="9139"
bid="5.150"
bid_size="100"
book_value="2.911"
change="-0.279"
change_from_200_day_moving_average="0.419"
change_from_50_day_moving_average="1.429"
change_from_52_week_high="-3.619"
change_From_52_week_low="3.111"
change_in_percent="-2.622%"
close="10.361"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.643"
ebitda="0.00"
eps_estimate_current_year="-1.990"
eps_estimate_next_quarter="-0.540"
eps_estimate_next_year="-1.850"
ex_dividend_date="N/A"
float_shares="3362000"
high="10.630"
high_52_weeks="13.980"
last_trade_date="1/30/2017"
last_trade_price="10.361"
last_trade_size="100"
last_trade_time="3:59pm"
low="10.250"
low_52_weeks="7.250"
market_capitalization="96.05M"
moving_average_200_day="9.942"
moving_average_50_day="8.932"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.750"
open="10.610"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+4.211%"
percent_change_from_50_day_moving_average="+16.003%"
percent_change_from_52_week_high="-25.886%"
percent_change_from_52_week_low="+42.910%"
previous_close="10.640"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.655"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.360"
stock_exchange="NGM"
symbol="GEMP"
volume="5965"
weeks_range_52="7.250 - 13.980"
